Craft

CJ Bioscience

Stock Price

₩15.9 K

2024-03-28

Revenue

₩4.1 B

FY, 2022

CJ Bioscience Summary

Company Summary

Overview
CJ Bioscience (씨제이바이오사이언스, formerly known as ChunLab) is a next-generation sequencing and bioinformatics service provider offering an end-to-end solution from sample to discovery. It offers optimized bioinformatics pipelines for various research disciplines, such as metagenomics, genomics, and transcriptomics, to enable clients to perform analytics of their NGS data. Its software tools include CLcommunity for microbial community analysis, CLgenomics for whole-genome analysis, and CLRNASeq for transcriptomics analysis.
Type
Public
Status
Active
Founded
2009
HQ
KR | view all locations
Website
https://www.cjbioscience.com/eng
Cybersecurity rating
Sectors

LocationsView all

2 locations detected

  • Seoul HQ

    Korea (Republic of)

    2477 Nambusunhwan-ro, Seocho-dong, Seocho-gu

  • Seoul

    Korea (Republic of)

    34 Samseong-ro 85-gil, Daechi-dong, Gangnam-gu

CJ Bioscience Financials

Summary Financials

Revenue (Q3, 2023)
₩1.7B
Gross profit (Q3, 2023)
(₩2.1B)
Net income (Q3, 2023)
(₩7.8B)
Cash (Q3, 2023)
₩38.7B
EBIT (Q3, 2023)
(₩7.9B)

Footer menu